KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Receivables (2016 - 2026)

Eli Lilly filings provide 18 years of Receivables readings, the most recent being $21.2 billion for Q1 2026.

  • On a quarterly basis, Receivables rose 51.23% to $21.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $21.2 billion, a 51.23% increase, with the full-year FY2025 number at $20.2 billion, up 51.82% from a year prior.
  • Receivables hit $21.2 billion in Q1 2026 for Eli Lilly, up from $20.2 billion in the prior quarter.
  • In the past five years, Receivables ranged from a high of $21.2 billion in Q1 2026 to a low of $7.7 billion in Q2 2022.
  • Median Receivables over the past 5 years was $11.3 billion (2023), compared with a mean of $12.5 billion.
  • Biggest five-year swings in Receivables: increased 5.31% in 2022 and later surged 61.45% in 2025.
  • Eli Lilly's Receivables stood at $8.6 billion in 2022, then skyrocketed by 32.45% to $11.3 billion in 2023, then increased by 17.11% to $13.3 billion in 2024, then surged by 51.82% to $20.2 billion in 2025, then rose by 5.07% to $21.2 billion in 2026.
  • The last three reported values for Receivables were $21.2 billion (Q1 2026), $20.2 billion (Q4 2025), and $19.5 billion (Q3 2025) per Business Quant data.